Pharmaceutical glassmaker Corning Incorporated will receive $204 million from the US government to expand the manufacturing capacity of its Valor glass vials used to store coronavirus vaccines and treatments.

The investment will enable Corning to increase the manufacturing capabilities of its three US facilities in Big Flats, New York; Durham, North Carolina; and Vineland, New Jersey.

The increase in vial manufacturing surge capacity will help meet the rapidly growing demand for glass containers as pharmaceutical companies enter Covid-19 clinical trials towards eventual approval of vaccines and treatments.

Wendell P. Weeks, Corning’s chairman and chief executive officer, said: “Corning is ready to do our part in the fight against the pandemic, as well as to help prepare for future public health emergencies.”